InvestorsHub Logo
Followers 48
Posts 8630
Boards Moderated 0
Alias Born 05/27/2011

Re: longfellow95 post# 238236

Friday, 08/02/2019 9:06:42 AM

Friday, August 02, 2019 9:06:42 AM

Post# of 718030
Thank you longfellow. No wonder why LP kept this trial this long. So enough has occured to set the 5 yr OS for DCvax-l trial set in stone. To any competitors who disagree like Dr Stupp for example, NWBO would just let them peruse the numbers of these survivors themselves.

These are undeniable numbers based on actual number of survivors.

In case of optune, their OS numbers looks pretty decent but DCvax-l number will beat those numbers imo.

In case of optune, if they cannot back up those numbers with actual long tails of survivors, then that is not good for the patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News